Addtech Life Science
Addtech Life Science's net sales were SEK 1,141 million (1,002), a 14 percent increase. Operating profit amounted to SEK 108 million (98). With a good final quarter, the business area for the first time achieved a full-year operating profit in excess of SEK 100 million. The growth in sales and profit came from a combination of solid organic growth and strategic acquisitions. Demand for diagnostic equipment and reagents from the Nordic healthcare sector was upbeat throughout the entire financial year. The market for measuring and analysis instruments for the Nordic process industry remained unchanged during the year, although the fourth quarter was weaker because of shifts in deliveries in certain projects. The market for equipment for Nordic healthcare and research laboratories, which was stable during the year, ended with a strong final quarter with several substantial instrument sales.
During the year the business area carried out three acquisitions, of Leica Nilomark OY, Active Care Sverup AB and Norsk Analyse AS.
|Addtech Life Science|
|Net sales, SEKm||1,141||1,002|
|Operating profit, SEKm||108||98|
|Operating margin, %||9.5||9.8|
|Working capital year average, SEKm||147||121|
|Return on working capital (P/WC), %||74||81|
|Investments in property, plant and equipment, SEKm||9||14|
|Average number of employees||347||299|